Bedrijfstakpensioenfonds Voor De Media PNO’s Regeneron Pharmaceuticals REGN Stock Holding History

Bedrijfstakpensioenfonds Voor De Media PNO’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,610	Closed	-$1.01M	–	250
2017 Q1	$1.01M	Hold	2,610	–	–	0.12%	145
2016 Q4	$958K	Hold	2,610	–	–	0.12%	149
2016 Q3	$1.05M	Hold	2,610	–	–	0.13%	109
2016 Q2	$911K	Hold	2,610	–	–	0.12%	142
2016 Q1	$941K	Sell	2,610 -800	-23%	-$330K	0.14%	126
2015 Q4	$1.85M	Hold	3,410	–	–	0.24%	36
2015 Q3	$1.59M	Hold	3,410	–	–	0.21%	43
2015 Q2	$1.74M	Hold	3,410	–	–	0.21%	40
2015 Q1	$1.54M	Sell	3,410 -190	-5%	-$80.5K	0.18%	53
2014 Q4	$1.48M	Hold	3,600	–	–	0.18%	39
2014 Q3	$1.3M	Hold	3,600	–	–	0.16%	46
2014 Q2	$1.02M	Hold	3,600	–	–	0.13%	162
2014 Q1	$1.08M	Buy	+3,600	New	+$1.11M	0.15%	95

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Bedrijfstakpensioenfonds Voor De Media PNO's REGN Position: Q2 2017 in Review

Bedrijfstakpensioenfonds Voor De Media PNO sold out of Regeneron Pharmaceuticals (REGN) in Q2 2017, closing a stake of 2,610 shares — an estimated $1.01M sold.

Bedrijfstakpensioenfonds Voor De Media PNO first reported a position in REGN in Q1 2014 and held it in 13 quarters. The position peaked at $1.85M in Q4 2015. 604 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

Bedrijfstakpensioenfonds Voor De Media PNO reported no remaining Regeneron Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Bedrijfstakpensioenfonds Voor De Media PNO sold 2,610 Regeneron Pharmaceuticals shares in Q2 2017, an estimated $1.01M.
Bedrijfstakpensioenfonds Voor De Media PNO first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 13 quarters.
Bedrijfstakpensioenfonds Voor De Media PNO's Regeneron Pharmaceuticals position peaked at $1.85M in Q4 2015.
604 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on Bedrijfstakpensioenfonds Voor De Media PNO's 13F filing for Q2 2017, filed 19 Jul 2017.